These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 6167667

  • 1. Antigenic differences between the membrane antigen polypeptides determined by different EB virus isolates.
    Franklin SM, North JR, Morgan AJ, Epstein MA.
    J Gen Virol; 1981 Apr; 53(Pt 2):371-6. PubMed ID: 6167667
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus strain- and group-specific antigenic determinants detected by monoclonal antibodies.
    Mueller-Lantzsch N, Georg-Fries B, Herbst H, zur Hausen H, Braun DG.
    Int J Cancer; 1981 Sep 15; 28(3):321-7. PubMed ID: 6172392
    [Abstract] [Full Text] [Related]

  • 3. Observations on the EB virus envelope and virus-determined membrane antigen (MA) polypeptides.
    North JR, Morgan AJ, Epstein MA.
    Int J Cancer; 1980 Aug 15; 26(2):231-40. PubMed ID: 6162806
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity.
    Rowe M, Hildreth JE, Rickinson AB, Epstein MA.
    Int J Cancer; 1982 Apr 15; 29(4):373-81. PubMed ID: 6282762
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220.
    Sairenji T, Bertoni G, Medveczky MM, Medveczky PG, Nguyen QV, Humphreys RE.
    J Virol; 1988 Aug 15; 62(8):2614-21. PubMed ID: 2839689
    [Abstract] [Full Text] [Related]

  • 6. A novel surface antigen on lymphoid cells transformed by Epstein-Barr virus.
    Hinuma Y, Sakamoto K.
    IARC Sci Publ (1971); 1978 Aug 15; (24 Pt 1):249-51. PubMed ID: 87368
    [Abstract] [Full Text] [Related]

  • 7. Demonstration of a surface antigen on Epstein-Barr virus genome-carrying lymphoid cells: distinction from the virus-determined membrane antigen.
    Sakamoto K, Hinuma Y.
    J Immunol; 1978 May 15; 120(5):1702-8. PubMed ID: 207776
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
    Sairenji T, Reisert PS, Spiro RC, Connolly T, Humphreys RE.
    J Exp Med; 1985 May 01; 161(5):1097-111. PubMed ID: 2580934
    [Abstract] [Full Text] [Related]

  • 9. Appearance of early and late components of Epstein-Barr virus-associated membrane antigen in Daudi cells superinfected with P3HR-1 virus.
    Sairenji T, Hinuma Y, Sekizawa T, Yoshida M.
    J Gen Virol; 1978 Jan 01; 38(1):111-20. PubMed ID: 202665
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus induced proteins V: comparison of EBV-specific polypeptides from different virus strains.
    Georg-Fries B, Mueller-Lantzsch N.
    Med Microbiol Immunol; 1982 Jan 01; 171(1):11-21. PubMed ID: 6289060
    [Abstract] [Full Text] [Related]

  • 11. Purification and properties of the gp340 component of Epstein-Barr virus membrane antigen in an immunogenic form.
    Morgan AJ, North JR, Epstein MA.
    J Gen Virol; 1983 Feb 01; 64 (Pt 2)():455-60. PubMed ID: 6300296
    [Abstract] [Full Text] [Related]

  • 12. Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.
    Epstein MA, Morgan AJ.
    Clin Exp Immunol; 1983 Aug 01; 53(2):257-71. PubMed ID: 6309441
    [No Abstract] [Full Text] [Related]

  • 13. Quantification of an Epstein-Barr virus-associated membrane antigen component.
    North JR, Morgan AJ, Thompson JL, Epstein MA.
    J Virol Methods; 1982 Sep 01; 5(1):55-65. PubMed ID: 6292251
    [Abstract] [Full Text] [Related]

  • 14. Correlation between Epstein-Barr virus membrane antigen and three large cell surface glycoproteins.
    Strnad BC, Neubauer RH, Rabin H, Mazur RA.
    J Virol; 1979 Dec 01; 32(3):885-94. PubMed ID: 92577
    [Abstract] [Full Text] [Related]

  • 15. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection and interference.
    Miller G, Robinson J, Heston L, Lipman M.
    IARC Sci Publ (1971); 1975 Dec 01; (11 Pt 1):395-408. PubMed ID: 190145
    [Abstract] [Full Text] [Related]

  • 16. Neutralization of lymphocyte immortalization by different strains of Epstein-Barr virus with a murine monoclonal antibody.
    Miller G, Heston L, Hoffman G.
    Infect Immun; 1982 Sep 01; 37(3):1028-31. PubMed ID: 6182100
    [Abstract] [Full Text] [Related]

  • 17. Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines.
    Gerber P, Ablashi D, Magrath I, Armstrong G, Andersen P, Trach L.
    J Natl Cancer Inst; 1982 Sep 01; 69(3):585-90. PubMed ID: 6287082
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference.
    Miller G, Robinson J, Heston L, Lipman M.
    Proc Natl Acad Sci U S A; 1974 Oct 01; 71(10):4006-10. PubMed ID: 4372601
    [Abstract] [Full Text] [Related]

  • 20. Polypeptides of the Epstein-Barr virus membrane antigen complex.
    Thorley-Lawson DA, Edson CM.
    J Virol; 1979 Nov 01; 32(2):458-67. PubMed ID: 228070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.